Time for an individualized approach to first-line management of follicular lymphoma by Guillaume Cartron, Judith Trotman

Get full text

Dissecting the NK Cell Population in Hematological Cancers Confirms the Presence of Tumor Cells and Their Impact on NK Population Function by Dang-Nghiem Vo, Michael Constantinides, Nerea Allende-Vega, Catherine Alexia, Guillaume Cartron, Martin Villalba

Get full text

miRNA profile at diagnosis predicts treatment outcome in patients with B-chronic lymphocytic leukemia: A FILO study by Isabelle Duroux-Richard, Anne-Laure Gagez, Elina Alaterre, Rémi Letestu, Olfa Khalifa, Christian Jorgensen, Christian Jorgensen, Stéphane Leprêtre, Emmanuelle Tchernonog, Jérôme Moreaux, Jérôme Moreaux, Jérôme Moreaux, Guillaume Cartron, Guillaume Cartron, Florence Apparailly, Florence Apparailly

Get full text

PB2455: THE DARK SIDE OF FECAL MICROBIOTA TRANSPLANTATION IN REFRACTORY ACUTE GASTROINTESTINAL GRAFT VERSUS HOST DISEASE. by Oumayma Hari, Rayane Berrahouane, Agathe Artiaga, Lilia Simonetti, Benoit Tisserand, Charles Herbaux, Guillaume Cartron, Patrice Ceballos

Get full text

Rationale for optimal obinutuzumab/GA101 dosing regimen in B-cell non-Hodgkin lymphoma by Guillaume Cartron, Florence Hourcade-Potelleret, Franck Morschhauser, Gilles Salles, Michael Wenger, Anna Truppel-Hartmann, David J. Carlile

Get full text

Circulating miRNA-125b Is a Potential Biomarker Predicting Response to Rituximab in Rheumatoid Arthritis by Isabelle Duroux-Richard, Yves-Marie Pers, Sylvie Fabre, Meryem Ammari, Dominique Baeten, Guillaume Cartron, Isabelle Touitou, Christian Jorgensen, Florence Apparailly

Get full text

Matching-adjusted indirect treatment comparison of liso-cel versus axi-cel in relapsed or refractory large B cell lymphoma by David G. Maloney, John Kuruvilla, Fei Fei Liu, Ana Kostic, Yeonhee Kim, Ashley Bonner, Yixie Zhang, Christopher P. Fox, Guillaume Cartron

Get full text

Preventive plasmapheresis for rituximab related flare in cryoglobulinemic vasculitis by Léa Fornero, Tarik Kanouni, Jean-Jacques Tudesq, Camille Pochard, Pauline Verot, Wendy Renier, Ludovic Gabellier, Guillaume Cartron, Philippe Guilpain, Charles Herbaux

Get full text

Matching-adjusted indirect treatment comparison of chimeric antigen receptor T-cell therapies for third-line or later treatment of relapsed or refractory large B-cell lymphoma: lis... by Guillaume Cartron, Christopher P. Fox, Fei Fei Liu, Ana Kostic, Jens Hasskarl, Daniel Li, Ashley Bonner, Yixie Zhang, David G. Maloney, John Kuruvilla

Get full text

Combined inhibition of Wee1 and Chk1 as a therapeutic strategy in multiple myeloma by Angélique Bruyer, Laure Dutrieux, Hugues de Boussac, Thibaut Martin, Djamila Chemlal, Djamila Chemlal, Nicolas Robert, Guilhem Requirand, Guillaume Cartron, Guillaume Cartron, Laure Vincent, Charles Herbaux, Charles Herbaux, Charles Herbaux, Malik Lutzmann, Caroline Bret, Caroline Bret, Caroline Bret, Philippe Pasero, Jérôme Moreaux, Jérôme Moreaux, Jérôme Moreaux, Jérôme Moreaux, Sara Ovejero, Sara Ovejero

Get full text

FCGR3A F158V alleles frequency differs in multiple myeloma patients from healthy population by Michaël Constantinides, Nicolas Robert, Caroline Multrier, Loïs Coënon, Mauricio Campos-Mora, Carine Jacquard, Fei Gao, Sara Zemiti, Jessy Presumey, Guillaume Cartron, Jérome Moreaux, Martin Villalba

Get full text

Identification of Anti-tumor Cells Carrying Natural Killer (NK) Cell Antigens in Patients With Hematological Cancers by Ewelina Krzywinska, Nerea Allende-Vega, Amelie Cornillon, Dang-Nghiem Vo, Laure Cayrefourcq, Catherine Panabieres, Carlos Vilches, Julie Déchanet-Merville, Yosr Hicheri, Jean-François Rossi, Guillaume Cartron, Martin Villalba

Get full text

SUMOylation inhibitor TAK-981 (subasumstat) synergizes with 5-azacytidine in preclinical models of acute myeloid leukemia by Ludovic Gabellier, Marion De Toledo, Mehuli Chakraborty, Dana Akl, Rawan Hallal, Mays Aqrouq, Giovanni Buonocore, Clara Recasens-Zorzo, Guillaume Cartron, Abigaïl Delort, Marc Piechaczyk, Denis Tempé, Guillaume Bossis

Get full text

P1090: LONG TERM FOLLOW-UP OF UNTREATED/RELAPSING MCL PATIENTS WITH THE IBRUTINIB, OBINUTUZUMAB, AND VENETOCLAX COMBINATION. by Steven Le Gouill, Franck Morschhauser, David Chiron, Kamal Bouabdallah, Guillaume Cartron, Rene Olivier Casasnovas, Caroline Milin, Charles Herbaux, Emmanuelle Tchernonog, Cedric Rossi, Simon Rule, Thomas Gastinne, Mary Callanan, Benoit Tessoulin

Get full text

Kinome expression profiling to target new therapeutic avenues in multiple myeloma by Hugues de Boussac, Angélique Bruyer, Michel Jourdan, Anke Maes, Nicolas Robert, Claire Gourzones, Laure Vincent, Anja Seckinger, Guillaume Cartron, Dirk Hose, Elke De Bruyne, Alboukadel Kassambara, Philippe Pasero, Jérôme Moreaux

Get full text

Generation of non-genetically modified, CAR-like, NK cells by Martine Pugnière, Bruno Robert, Pierre Martineau, Loïs Coënon, Jessy Présumey, Emilie Rigal, Hortense Courot, Caroline Multrier, Sara Zemiti, Jennifer Lambour, Marion de Toledo, Guillaume Bossis, Guillaume Cartron, Bénédicte Fauvel, Martin Villalba

Get full text

Comparative analysis of CAR T-cell therapy access for DLBCL patients: associated challenges and solutions in the four largest EU countries by Miguel Á. Canales Albendea, Pier Luigi Canonico, Guillaume Cartron, Barthold Deiters, Claudio Jommi, Reinhard Marks, Catherine Rioufol, Catherine Rioufol, Juan M. Sancho Cia, Armando Santoro, Armando Santoro, Eva M. Wagner-Drouet

Get full text

The NADPH oxidase NOX2 is a marker of adverse prognosis involved in chemoresistance of acute myeloid leukemias by Rosa Paolillo, Mathias Boulanger, Pierre Gâtel, Ludovic Gabellier, Marion De Toledo, Denis Tempé, Rawan Hallal, Dana Akl, Jérôme Moreaux, Hayeon Baik, Elise Gueret, Christian Recher, Jean-Emmanuel Sarry, Guillaume Cartron, Marc Piechaczyk, Guillaume Bossis

Get full text

CD45 Isoform Profile Identifies Natural Killer (NK) Subsets with Differential Activity. by Ewelina Krzywinska, Amelie Cornillon, Nerea Allende-Vega, Dang-Nghiem Vo, Celine Rene, Zhao-Yang Lu, Christine Pasero, Daniel Olive, Nathalie Fegueux, Patrick Ceballos, Yosr Hicheri, Michal Sobecki, Jean-François Rossi, Guillaume Cartron, Martin Villalba

Get full text

Venetoclax plus bendamustine-rituximab or bendamustine-obinutuzumab in chronic lymphocytic leukemia: final results of a phase Ib study (GO28440) by Stephan Stilgenbauer, Franck Morschhauser, Clemens-Martin Wendtner, Guillaume Cartron, Michael Hallek, Barbara Eichhorst, Mark F. Kozloff, Thomas Giever, Gerard Lozanski, Yanwen Jiang, Huang Huang, Daniela Soriano Pignataro, William Schary, Kathryn Humphrey, Mehrdad Mobasher, Gilles Salles

Get full text